Share Price:

APNASPENAspen Pharmacare Hldgs9203103 (1.13%)

H1 2025 Interim Results Booklet

View or Download

H1 2025 Interim Results Presentation

View or Download

FY 2025 Annual Results Presentation

View or Download

Aspen delivers strong results and advances its strategic ambitions

Stephen Saad Aspen Group Chief Executiv

Aspen Pharmacare Holdings has reported positive Group interim financial results for the six months ended 31 December 2024.

Stakeholder Notes – 23 April 2025

View or Download

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below: